The effect of jujube and saffron supplement on Covid-19

Phase 3

• Conditions: Covid-19.; Covid-19; U07.1

• Registration Number: IRCT20160305026917N2
• Lead Sponsor: Birjand University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Clinical or paraclinical confirmation of disease
Absence of underlying disease including diabetes, thyroid disorders, cardiovascular, autoimmune, and hemorrhagic and other lung diseases
No pregnancy and breastfeeding.

Exclusion Criteria

Patients with severe forms of the disease (patients under ventilator, patients with oxygen saturation below 88 mm Hg, and patients admitted to the ICU
The patient's unwillingness to continue participating in the project
Sensitivity to the components of the supplement.

Study & Design

• Study Type: interventional
• Study Design: Not specified